Abbott (NYSE: ABT) and Cardiovascular Systems, Inc. (CSI), have announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. Under terms of the agreement, CSI stockholders will receive $20 per common share at a total expected equity value of approximately $890 million. CSI is a leader in devices for atherectomy, a minimally invasive treatment for plaque build-up in arteries that can restrict blood flow. Procedural use of atherectomy can help maximize the benefits of standard balloon angioplasty or stent treatments in restoring blood flow in complex arterial disease. CSI also has an early-stage pipeline of complementary vascular intervention devices in development.
Read the full article: Abbott to Acquire Cardiovascular Systems, Inc.
Source: https://www.prnewswire.com/news-releases/abbott-to-acquire-cardiovascular-systems-inc-301742551.html